Gotham Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-18,994
| Closed | -$298K | – | 1250 |
|
|
2021
Q4 | $298K | Buy |
18,994
+4,695
| +33% | +$73.7K | 0.01% | 945 |
|
|
2021
Q3 | $245K | Sell |
14,299
-583
| -4% | -$9.99K | 0.01% | 906 |
|
|
2021
Q2 | $320K | Buy |
14,882
+4,664
| +46% | +$100K | 0.01% | 824 |
|
|
2021
Q1 | $153K | Sell |
10,218
-3,839
| -27% | -$57.5K | 0.01% | 964 |
|
|
2020
Q4 | $185K | Sell |
14,057
-19,104
| -58% | -$251K | 0.01% | 943 |
|
|
2020
Q3 | $320K | Sell |
33,161
-47,369
| -59% | -$457K | 0.01% | 828 |
|
|
2020
Q2 | $921K | Sell |
80,530
-77,054
| -49% | -$881K | 0.03% | 579 |
|
|
2020
Q1 | $1.63M | Sell |
157,584
-3,608
| -2% | -$37.4K | 0.05% | 449 |
|
|
2019
Q4 | $2.65M | Sell |
161,192
-1,422
| -0.9% | -$23.3K | 0.05% | 396 |
|
|
2019
Q3 | $2.16M | Buy |
162,614
+127,061
| +357% | +$1.69M | 0.04% | 441 |
|
|
2019
Q2 | $501K | Sell |
35,553
-8,729
| -20% | -$123K | 0.01% | 802 |
|
|
2019
Q1 | $815K | Buy |
44,282
+19,818
| +81% | +$365K | 0.01% | 707 |
|
|
2018
Q4 | $639K | Buy |
+24,464
| New | +$639K | 0.01% | 720 |
|
|
2017
Q4 | – | Sell |
-142,159
| Closed | -$2.55M | – | 1070 |
|
|
2017
Q3 | $2.55M | Sell |
142,159
-31,764
| -18% | -$569K | 0.04% | 476 |
|
|
2017
Q2 | $2.84M | Buy |
173,923
+5,970
| +4% | +$97.3K | 0.04% | 462 |
|
|
2017
Q1 | $2.35M | Buy |
167,953
+107,736
| +179% | +$1.51M | 0.03% | 526 |
|
|
2016
Q4 | $960K | Buy |
60,217
+32,973
| +121% | +$526K | 0.01% | 627 |
|
|
2016
Q3 | $453K | Buy |
27,244
+12,940
| +90% | +$215K | 0.01% | 729 |
|
|
2016
Q2 | $160K | Buy |
+14,304
| New | +$160K | ﹤0.01% | 900 |
|